Soy and soy isoflavones are alleviating skin and lung toxicities from thoracic radiotherapy in preclinical study models; however, researchers stress the need for further studies.
Respiratory motion management reduces radiation exposure to nontarget tissues in patients undergoing treatment of cancers in the chest and abdomen.
These tools can help clinicians determine which treatments are ideal and explain to patients what their best options are and why.
Management of bone metastasis is an increasingly common challenge. Palliative radiotherapy is proving to effectively relieve pain and improve quality of life for patients.
Few patients with HCC are candidates for curative treatment at diagnosis. However, a new study demonstrated that stereotactic body radiotherapy...
The key to managing this late effect is patient education because it can manifest long after patients complete radiotherapy.
A common side effect of cancer treatment, including radiotherapy, is diarrhea. Treatment is based on its cause and severity.
Proposed reductions in radiotherapy prompted a joint reaction from ASTRO and other cancer care organizations.
Emerging combination radiotherapy regimens are improving overall survival; however, associated dermatologic toxicities pose unique challenges.
A new study suggests radiotherapy may hold clinical promise for the control of local lymph node bed recurrence of malignant melanoma.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|